These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 26235479)

  • 1. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
    Schaub M; Fanghaenel K; Stohler R
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1060-5. PubMed ID: 19016094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for increased substance use in psychosis.
    Gregg L; Barrowclough C; Haddock G
    Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cannabis use a contributory cause of psychosis?
    Degenhardt L; Hall W
    Can J Psychiatry; 2006 Aug; 51(9):556-65. PubMed ID: 17007222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
    Flanders SE
    Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early adolescent cannabis exposure and positive and negative dimensions of psychosis.
    Stefanis NC; Delespaul P; Henquet C; Bakoula C; Stefanis CN; Van Os J
    Addiction; 2004 Oct; 99(10):1333-41. PubMed ID: 15369572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis--psychosis pathway independent of other types of psychopathology.
    Ferdinand RF; van der Ende J; Bongers I; Selten JP; Huizink A; Verhulst FC
    Schizophr Res; 2005 Nov; 79(2-3):289-95. PubMed ID: 16125368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and psychosis.
    Degenhardt L; Hall W
    Curr Psychiatry Rep; 2002 Jun; 4(3):191-6. PubMed ID: 12003681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.